Holen Sie sich die Stockscreener-App
160.39
1.02%
1.62
Vorhandelsmarkt:
159.55
-0.84
-0.52%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$158.77
Offen:
$159.37
24-Stunden-Volumen:
1.09M
Relative Volume:
0.69
Marktkapitalisierung:
$17.90B
Einnahmen:
$2.90B
Nettoeinkommen (Verlust:
$239.11M
KGV:
76.03
EPS:
2.1097
Netto-Cashflow:
$492.62M
1W Leistung:
+2.81%
1M Leistung:
+6.14%
6M Leistung:
+84.78%
1J Leistung:
+65.08%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$152.71
$161.67
52-Wochen-Spanne:
$81.22
$166.25
Revvity Inc Stock (RVTY) Company Profile
Firmenname
Revvity Inc
Sektor
Branche
Telefon
781-663-6900
Adresse
77 4TH AVENUE, WALTHAM
Compare RVTY vs TMO, DHR, NTRA, A, IQV
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
160.39 | 17.90B | 2.90B | 239.11M | 492.62M | 2.1097 |
TMO
Thermo Fisher Scientific Inc
|
684.89 | 253.24B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
232.97 | 163.77B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
404.90 | 58.36B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
175.96 | 49.61B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
273.60 | 45.03B | 16.63B | 1.39B | 2.12B | 8.0674 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-10-06 | Eingeleitet | William Blair | Outperform |
| 2026-09-09 | Fortgesetzt | UBS | Neutral |
| 2026-09-01 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2026-06-26 | Fortgesetzt | Bernstein | Mkt Perform |
| 2026-06-02 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2026-04-14 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-12-09 | Eingeleitet | Goldman | Neutral |
| 2025-10-16 | Eingeleitet | Guggenheim | Neutral |
| 2025-05-01 | Hochstufung | UBS | Neutral → Buy |
| 2025-01-10 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2024-12-13 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-10-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-07-08 | Eingeleitet | Leerink Partners | Outperform |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-01-16 | Herabstufung | UBS | Buy → Neutral |
| 2024-01-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-05-23 | Fortgesetzt | Goldman | Buy |
Alle ansehen
Revvity Inc Aktie (RVTY) Neueste Nachrichten
CareDx to Report Q3 Earnings: Transplant Testing Growth in Focus - Zacks Investment Research
Revvity, Inc. Estimates – NYSE:RVTY - TradingView
ELV vs. RVTY: Which Stock Is the Better Value Option? - Zacks Investment Research
Here's How IDEXX Laboratories Is Placed Ahead of Q3 Earnings - Zacks Investment Research
Revvity, Inc. (RVTY) Stock Forecasts - Yahoo! Finance Canada
Revvity: High PEG Ratio Leaves Limited Near-Term Upside (NYSE:RVTY) - Seeking Alpha
Revvity To Go Ex-Dividend On October 23rd, 2026 With 0.07 USD Dividend Per Share - Moomoo
Revvity Launches Signals LabGistics to Coordinate Scientific Workflows - Zacks Investment Research
Revvity Launches Signals LabGistics to Coordinate Scientific Workflows - Zacks Investment Research
Revvity: A Diagnostics Annuity Is Quietly Funding An AI Data Engine - Seeking Alpha
Revvity, Inc. (RVTY) Stock Forecasts - Yahoo Finance
Revvity, Inc. (RVTY) Stock forecasts - Yahoo Finance Singapore
RVTY: Revvity Inc. Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Revvity, Inc. (PKN.DE) stock price, news, quote and history - Yahoo Finance UK
Revvity, Inc. (PKN.DE) Stock Price, News, Quote & History - Yahoo! Finance Canada
A Look at Revvity Inc (RVTY) After 3.4% Gain -- GF Value $117.52 vs Price $156.01 - GuruFocus
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
Citrini Bets on Life Sciences Stocks After Claude AI Drug Study - Bloomberg.com
Revvity Launches Signals Labgistics Solution To Connect And Orchestrate Scientific Workflows - TradingView
Revvity Launches Signals LabGistics Solution to Connect and Orchestrate Scientific Workflows - Business Wire
Revvity Inc. stock outperforms competitors despite losses on the day - MarketWatch
Revvity Inc. stock outperforms competitors despite losses on the day - MarketWatch
J.P. Morgan Maintains Revvity(RVTY.US) With Hold Rating, Raises Target Price to $155 - Moomoo
Revvity (NYSE:RVTY) Stock Price - Simply Wall Street
Revvity Inc. stock underperforms Friday when compared to competitors - MarketWatch
ETFs Are Net Sellers of Revvity (RVTY) on Wednesday - Yahoo Finance
Revvity Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Revvity (RVTY), What Is Drawing Fresh Attention Now? - Yahoo Finance
Revvity (RVTY) Stock Could Be 12% Stretched On Cash Flow - Yahoo Finance
Revvity, Inc. (RVTY) Stock Forecasts - Yahoo Finance
Revvity Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
JPMorgan Adjusts Price Target on Revvity to $155 From $110 - www.marketscreener.com
Revvity, Inc. (RVTY.MX) stock price, news, quote and history - Yahoo Finance UK
Avoiding Lag: Real-Time Signals in (RVTY) Movement - Stock Traders Daily
Here's How Much $100 Invested In Revvity 15 Years Ago Would Be Worth Today - Benzinga
Revvity to Present at Upcoming Investor Conferences - StreetInsider
Thermo Fisher to Report Q3 Earnings: What's in the Cards? - Zacks Investment Research
Revvity to Present at Upcoming Investor Conferences - Business Wire
TD Cowen Adjusts Price Target on Revvity to $175 From $130 - www.marketscreener.com
Revvity to Present at Upcoming Investor Conferences - Yahoo Finance
Revvity, Inc. (RVTY) Stock forecasts - Yahoo Finance UK
US714046AH29 Bond Profile: Coupon and Redemption - TradingView
Revvity, Inc. Stock 12‑Month Price Target Raised to $142.93, Implies 6% Downside - TradingView
Revvity, Inc. (RVTY) Stock forecasts - Yahoo Finance UK
Revvity, Inc. (RVTY) Stock Forecasts - Yahoo! Finance Canada
What Does Revvity (NYSE:RVTY) New Assay Add to NYSE Composite? - Kalkine Media
Baird Adjusts Price Target on Revvity to $164 From $144 - Yahoo Finance
Revvity, Inc. (RVTY) Stock Forecasts - Yahoo Finance
T. Rowe Price reports sole voting power over 12.9M shares in Revvity (RVTY). - Stock Titan
Revvity Inc (RVTY) Stock Earnings Transcripts - GuruFocus
Finanzdaten der Revvity Inc-Aktie (RVTY)
Umsatz
Nettogewinn
Free Cashflow
ENV
Revvity Inc-Aktie (RVTY) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Gonzales Anita | Officer |
Oct 01 '26 |
Proposed Sale |
155.48 |
84 |
13,060 |
0 |
| Krakowiak Maxwell | Officer |
Sep 21 '26 |
Proposed Sale |
144.53 |
1,631 |
235,728 |
0 |
| Krakowiak Maxwell | Please See Remarks |
Sep 21 '26 |
Sale |
144.53 |
1,631 |
235,728 |
14,781 |
| Vohra Tajinder S | Please See Remarks |
Sep 16 '26 |
Sale |
140.88 |
7,330 |
1,032,650 |
6,635 |
| Vohra Tajinder S | Officer |
Sep 16 '26 |
Proposed Sale |
140.88 |
7,330 |
1,032,650 |
0 |
| Gonzales Anita | Officer |
Jul 20 '26 |
Proposed Sale |
109.48 |
85 |
9,306 |
0 |
| Gonzales Anita | Vice President and CAO |
Jul 20 '26 |
Sale |
109.48 |
85 |
9,306 |
7,201 |
| Gonzales Anita | Officer |
Apr 20 '26 |
Proposed Sale |
92.80 |
80 |
7,424 |
0 |
| Gonzales Anita | Vice President and CAO |
Apr 20 '26 |
Sale |
92.80 |
80 |
7,424 |
7,319 |
| Victor Miriame | Please See Remarks |
Feb 24 '26 |
Option Exercise |
95.74 |
1,862 |
178,268 |
19,984 |
3.45%
0.80%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):